תעשיית תרופות המקור בישראל 2014

  • Published on
    01-Apr-2016

  • View
    235

  • Download
    13

Embed Size (px)

DESCRIPTION

2014 : , ,

Transcript

  • 4102

    -noitaN amrahP

  • 2

  • .

    , . , : - -006,1 , , , ; - , , , ; - ,

    .

    , . %2 , %6 . , -.

    .

    :

    :

    , :

    - - %01 56 (-008 ), . , , 56 . , ,

    .

    - , . , , , -%57

    . - , , , - . , , ,

    . , , : -5.1 , -51-01 , 000,5:1. , , ,

    , .

    , , , , - ,

    .

    , ,

    .

    3

  • , . , ,

    .

    . , ,

    .

    , .

    , .

    .

    , , .

    4

  • ,

    , .

    4102 -noitaN amrahP, : , , .

    , .

    , , , . . , , , , .

    .

    . , .

    . . : , , , , .

    . 02 . , . , . , , ,

    .

    , ,

    ,

    5

  • 6

  • 32-81

    - 72-42

    71-01

    -noitaN amrahP 33-82

    7

  • . , , , . , , ,

    . . . , -%6 . , ., ,

    , . . , , ; , , ; , ; , .

    : -5.1

    : 51-01

    : 000,5:1

    )IOR - tnemtsevnI nO nruteR(: 3:1

    , , ,

    .

    : -000,3

    : -006,1

    -001 ,

    , :

    8

  • .

    - , , , ; , . , , . , . , , . , ,

    - . ,

    .

    . , , . , . . , , noitaN-amrahP.

    , . . ,

    - , , . , , -noitaN-amrahP.

    - :

    , ,

    ,

    ,

    , ,

    , ,

    - :

    , ,

    :

    ,

    ecnaligivocamrahp

    -

    :

    -

    - , ,

    ,

    ,

    -

    , ,

    -

    ,

    - %57! , %07

    , -%84 !

    noitaN-amrahP

    9

  • 1

  • ,

    , .

    , , .

    .

    . .

    , . , -%04. . , -%85

    -%08 .[7]

    %54 9991 -5002

    4102 ,muilisnoC-hctaguP :sisylanA ;7002 ,.lA te xoF .A.K :ecruoS

    -

    -

    -

    %52

    %02

    %51

    %01

    %5

    %0%2

    %08.4

    %04.8

    %06.4

    %11

    %05.91

    9991

    5002

    4102 ,muilisnoC-hctaguP :sisylanA ;eraC rof snoitacilpmI dna yrotcejarT pihsrovivruS ehT ssorcA ecnelaverP :setatS detinU ehT nI srovivruS recnaC .)3102( .lA te .S .J ,rooM eD :ecruoS

    01

    21

    41

    61

    81

    02

    8

    6

    4

    2

    02202 7102 2102 7002 2002 7991 2991 7891 2891 7791

    51

    01 - 51

    5 - 01

    - 5

    11

  • . , - . , - , -PDOC

    .

    . , -5.2 [51]. - , ,

    .[2]

    . -%37 8. -, , : -%08

    -09, , , .[01] , , ( ) ,

    .[11]

    ? 72.1 !

    21

  • 1

    )%(

    %99

  • . , , .

    -000,007 , .[3] 4-3 .

    , *

    ;3102 ,elfiorP yrtsudnI hcraeseR lacituecamrahpoiB ,AMRhP ;3102 ,serugiF ni yrtsudnI lacituecamrahP ehT ,AIPFE :ecruoS, - : ,11024102 ,muilisnoC-hctaguP :sisylanA

    0000061 0000041 0000021 0000001 000008 000006 000004 000002 0

    000,018

    000,095

    000,611

    005,21

    000,53

    000,07

    000,000,1

    000,001,1

    000,005,1

    1

    2 ,

    , ,

    3 ,

    ,

    41

  • . , , (snitats), . () ,

    . . ;

    -DCEO .[31,4] , , , , . , .[9] , .[41,5]

    1

    4102 ,muilisnoC-hctaguP :sisylanA ;3102 ,elfiorP yrtsudnI hcraeseR lacituecamrahpoiB ,AMRhP :ecruoS

    307,3 692,2 401,2

    205,1

    015,6-

    644,51-

    035,51-

    480,13-

    000,01

    000,5

    0

    000,5-

    000,01-

    000,51-

    000,02-

    000,52-

    000,03-

    000,53-

    -

    .

    -04 , , . , , ; , ,

    .[21]

    .

    : . - - ,

    -.

    *

    51

  • .

    , , , , , ,

    .

    .

    , - , . , , - , . , , .

    ? , )-%08( . 000,5 -000,7 .

    .

    , . ,

    , . ,

    , .

    ? , )sesaesiD laciporT dna detcelgeN(,

    , , . : )VIH(, . 71 ,

    . . [61] ,

    .

    AND

    - -000,000,51 " ,

    ,

    -000,000,054 " *

    -000,3

    -006,1

    -001 ,

    000,001

    -005,21

    005,21-000,001

    %57 -

    %57

    %77 %77

    *

    %07

    %84

    61

  • 1

    :

    1. .109-110 ' , : , .)2010( ,

    2. Canadian Public Health Association, (2001). The Value of Immunization in The Future of Canadas Health System.

    3. EFPIA, (2013). The Pharmaceutical Industry In Figures: Key Data, Belgium: EFPIA, p. 13

    4. Healy, P. (2011). Which Price is Right? Regulating the Cost of Pharmaceuticals in Europe and North America, The Stockholm Network, p. 4.

    5. Hermus, G. et Al. (2013). Reducing the Health Care and Societal Costs of Disease: The Role of Pharmaceuticals, The Conference Board of Canada Report.

    6. IFPMA, (2004). The Pharmaceutical Innovation Platform, Geneva, Switzerland, p. 17.

    7. Innovation.org, Saving and Improving Lives, Extending Lives.

    http://www.innovation.org/index.cfm/impactofinnovation/Saving&ImprovingLives#vii, Accessed 30.4.2014.

    8. Lichtenberg, F. R. (2013). Pharmaceutical Innovation and Longevity Growth In 30 Developing and High-Income Countries, 2000-2009, Health Policy and Technology, p. 11.

    9. Lichtenberg, F.R. (2013). The impact of pharmaceutical innovation on disability days and the use of medical services in the United States, 1997-2010, Columbia University and The National Bureau of Economic Research.

    10. PhRMA, (2012). Innovative Medicines Help Turn HIV Infection Into Chronic Disease,

    http://www.phrma.org/media/releases/innovative-medicines-help-turn-hiv-infection-chronic-disease.

    11. PhRMA, (2013). Rare Diseases: A Report On Orphan Drugs In The Pipeline. http://www.phrma.org/sites/default/files/pdf/Rare_Diseases_2013.pdf

    12. Pugatch Consilium, (2012). Assembling The Pharmaceutical R&D Puzzle for Needs In The Developing World, p. 19.

    13. Pugatch, M. P., Healy, P., Chu, R. (2010). Sharing The Burden: Could Risk-Sharing Change The Way We Pay For Healthcare?, The Stockholm Network, pp. 11-12;

    14. Santerre, R. (2011). National and International Tests of The New Drug Cost Offset Theory, Southern Economic Journal, Vol. 77, No. 4, pp. 1037-1040;

    15. WHO, UNICEF, World Bank, (2009). State of The World Vaccines and Immunization, 3rd Ed, Geneva: World Health Organization, p. 4.

    16. Ibid, note 12, pp 14-15

    17

  • 2

  • , , ,

    . - -

    .

    -: 3 -6 . , -052 - .[7] , ,

    %02.[1]

    : , , . 5 -7 , -%06, -%61. , 5 052

    , ; , , (tnemtsevnI nO nruteR)

    -%03.[11]

    -, :

    .

    , - , , ; , ,

    , . - (000,5-000,1 ) , -

    .[11,9]

    -

    ( VI)

    91

    %5.12

    %9.65

    %3.8%8.9

    %5.3

    .8%7

    1

    5.2 %

    %7.53

    I

    II

    III

  • , : . 6 -81 ( ), , (ecneligivocamrahP), , .

    01 -51 , -5.1 . 3002, 1991.[2] -005 0002, 5.84 -2102 .[8] , , . , 000,5:1, (IOR) 3:1. ,

    ,

    .[3]

    . : , , ,

    , .

    , , , - . ; . , ( ) , , -%03 .[01] , , , %75-%722 .[01]

    50029991

    )( ): , , (

    %56+85169

    ) (

    %76+5312

    %07+087064 )(

    )% (

    %12-9557

    )etar noitneter( )% (

    %03-8496

    ;3102 ,elfiorP yrtsudnI hcraeseR lacituecamrahpoiB ,AMRhP :ecruoS4102 ,muilisnoC-hctaguP :sisylanA

    , , - .[4] , . ,

    ; 0002, -%05 .[6] , , -

    .

    02

  • , : , . -ADF 72 , -%33

    ssalC-ni-tsriF ; C, II .[5]

    2

    12

    :

    2-3.0 7-6 6-3

    005-001000.5-000.1 001-02

    5

    052

    000.01-000.5

    III II I

    -

  • 1. EFPIA, (2013). The Pharmaceutical Industry In Figures: Key Data, Belgium, p. 8.

    2. Ibid., p. 9.

    3. Ibid., p. 10.

    4. European Medicines Agency, (2013). Better Vigilance for Public Health Protection: Overview of The New European Union Pharmacovigilance Legislation.

    5. FDA, (2014). Novel New Drugs: 2013 Summary, http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DrugInnovation/UCM381803.pdf

    6. IFPMA, (2004). The Pharmaceutical Innovation Platform, Geneva, Switzerland, p. 23.

    7. PhRMA, (2013). 2013 Biopharmaceutical Research Industry Profile, pp. 22-23.

    8. Ibid., p. 23.

    9. Ibid., p. 35.

    10. Ibid., p. 37.

    11. Pugatch Consilium, (2012). Assembling The Pharmaceutical R&D Puzzle for Needs In The Developing World, p. 17.

    :

    ,FDA-

    25

    30

    35

    40

    45

    20

    15

    10

    5

    0

    Source: FDA, (2014). Novel New Drugs: 2013 Summary

    2005 2006 2007 2008 2009 2010 2011 2012 2013

    38

    20

    26

    22

    35

    18

    34

    36

    26

    23

    41 41

    39

    27

    36

    30

    21

    24

    22

  • - 3

  • : -%055 , %6.2, -1102 5 .[6]

    , , .[5] , %32,

    .

    11020102

    : : : :

    521542151432

    , ,

    121063502434

    97795923878213

    5706157670263866

    3541197312416583

    612154811302152501

    03711775234971194703

    )( , 1102-0102:

    : (3102). () 1102.

    -

    . -08 . , . , - , - -

    .

    : , . -001 .[3] - , :

    . , , . , , , ,

    , *.

    : , ( 9A/8A) . , -006,1 - -, , , . , -51 ,

    , .[8]

    * : sitahw/li.oc.srotcod.slairtlacinilc//:ptth/ : .

    - 52

  • 3102:

    )(01

    000,955

    006,014

    709,472 .. (L.M.C)

    000,022

    007,891 -TSIG

    925,861

    120,161

    000,851

    000,251

    000,601

    , , , , , .[8] : , . , ,

    .

    . , , . - : , , , .[1] - , . , , , ; , .

    -62

  • .[2] - .[4] . , - , , . , , .[9] . , - , , -

    .

    3 -4 .[11]

    (slanoisseforP hcraeseR lacinilC), . 4002,[01] , . , , , , , . - , , , ;[8]

    .

    3

    :1. -, . (2102). - , ' 86, .

    2. , (4102). " : 3102 2102-0102.

    3. , (4102). " -, -, 3102", , .

    4. , (3102). , : , , ' 9.

    5. , (3102). , : , , ' 71.

    6. , (3102). , : , , ' 26.

    7. , (3102). , : , , ' 331.

    8. , (3102). " 2102.

    9. , (3102). .

    ,retpahC ilearsI zz tuobA ,learsI :sretpahC labolG :etaroballoC & tcennoC :emoH ,slanoisseforP hcraeseR lacinilC fo noitaicossA .01

    .4102.4.03 desseccA ,xpsa.retpahCilearsIehttuobA/learsI/sretpahClanoitanretnI/roFofnIteG/gro.tenprca.www//:ptth

    .4 .p ,AIPFE :muigleB ,ataD yeK :serugiF nI yrtsudnI lacituecamrahP ehT .)3102( ,AIPFE .11

    %57 -

    %57

    %77 %77

    ?

    %07

    %84

    - 72

  • -noitaN amrahP4

  • . : , , ; , , ;

    , ; : 4002, 4102 , ,

    ( :scihte/li.gro.learsi-amrahp.www//:ptth)

    :

    ecitcarP lacinilC dooG

    :

    - ecitcarP gnirutcafunaM dooG- - ecitcarP noitubirtsiD dooG

    ecnaligivocamrahP

    ,

    -

    ralimiS-oiB

    -amrahP noitaN : , , , -amrahP

    noitaN .

    . , %56 .[3] , . .

    . . ,

    .

    : , , .[1] ,

    , :

    -noitaN amrahP 92

  • . 5002, . , 5.6 5.5

    , .[2] , , . - -DCEO, , -21 . - , . , , - ,

    .

    . , noitisoppO tnarG-erP, . . . , , noitisoppO tnarG-tsoP, , - . , -, , -

    .

    . . :

    -dooG ecitcarP gnirutcafunaM, ecitcarP noitubirtsiD dooG, ,

    . , , , . -

    :

    ., -81 ; - . , , - , , ( )

    (goL-kcaB).

    )ralimiS-oiB(

    . . ( ) , (ralimiS-oiB) . (AME) -, , . (ralimiS-oiB), ; .[4] - -AME; ,

    .

    -noitaN amrahP 03

  • : :

    4

    ) (

    )%(

    2102

    (9A-8A )

    %76-44231

    ()

    %28-000,003992,996,1

    %59-943,03756,255

    3102

    (9A-8A )

    %25-55411

    ()

    %85-000,003214,217

    %36-842,792538,208

    4102

    (9A-8A )

    %93-9569

    ()

    %36-000,003978,618

    %08-213,511446,865

    . , , , . , , . - - ; ,

    ( 9A-8A) , . , , . , , %2 , .

    , .

    -noitaN amrahP 13

  • , . -8002, . , - . , 4102 03 - . , ,

    .

    , . . , , , , . , , - ,

    , . , , , .

    , , . . . ,

    .

    ,

    . - ,

    -noitaN amrahP.

    , 4102-4002

    * 4102 ,

    700,22

    333,0...